Medical Devices - Interventional Cardiology & Vascular Systems
Strategic Profile
The company provides PCI guide wires, guiding catheters, balloon catheters, and penetration catheters for cardiology, as well as peripheral guide wires, IVR guide wires, micro catheters, and cerebrovascular system guide wires, alongside OEM/ODM services. It also develops, manufactures, and sells ultra-fine stainless steel wire ropes, demonstrating manufacturing excellence in precision medical devices.
Cyborg Score Rationale
Asahi Intecc is a specialized player in high-growth interventional medical device markets with established global presence. Recent analyst upgrades and positive technical signals suggest market confidence, though operating margins face near-term pressure from cost inflation.
Top Insights
Specialized in interventional cardiology and vascular systems with limited direct competition in certain guide wire segments
2024 revenue of $830.6M represents 11.6% year-over-year growth
12 analysts recommend buying the stock with zero sell recommendations
Global operational footprint through subsidiaries in 10+ countries enables local market presence and supply chain resilience
Named Competitors
Interventional Cardiology Products — Diversified interventional medical device portfolio
Cardiology Devices — Broad cardiovascular and vascular device range
Structural Heart and Vascular — Large-scale medical technology conglomerate
Guide Wires and Catheters — Japanese competitor in interventional devices
Recent Developments
(March 2026) Jefferies upgrade reflects analyst confidence in growth prospects
(December 2025) Stock trading near 52-week highs with positive momentum
(2024) Revenue growth of 11.6% despite operating margin compression
Open the full interactive Asahi Intecc Co., Ltd. report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.